165 related articles for article (PubMed ID: 8099782)
21. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
22. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
23. Binding of cerebrosides and sulfatides to saposins A-D.
Soeda S; Hiraiwa M; O'Brien JS; Kishimoto Y
J Biol Chem; 1993 Sep; 268(25):18519-23. PubMed ID: 8360153
[TBL] [Abstract][Full Text] [Related]
24. Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.
Matzner U; Breiden B; Schwarzmann G; Yaghootfam A; Fluharty AL; Hasilik A; Sandhoff K; Gieselmann V
J Biol Chem; 2009 Apr; 284(14):9372-81. PubMed ID: 19224915
[TBL] [Abstract][Full Text] [Related]
25. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
[TBL] [Abstract][Full Text] [Related]
26. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
[TBL] [Abstract][Full Text] [Related]
28. Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators.
Madar-Shapiro L; Pasmanik-Chor M; Dinur T; Dagan A; Gatt S; Horowitz M
J Inherit Metab Dis; 1999 Jun; 22(5):623-37. PubMed ID: 10399095
[TBL] [Abstract][Full Text] [Related]
29. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
Rafi MA; Amini S; Zhang XL; Wenger DA
Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
[TBL] [Abstract][Full Text] [Related]
30. Sphingolipid hydrolase activator proteins and their precursors.
Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.
Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489
[TBL] [Abstract][Full Text] [Related]
32. Distribution of saposins (sphingolipid activator proteins) in tissues of lysosomal storage disease patients.
Tayama M; O'Brien JS; Kishimoto Y
J Mol Neurosci; 1992; 3(4):171-5. PubMed ID: 1389998
[TBL] [Abstract][Full Text] [Related]
33. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
Qi X; Leonova T; Grabowski GA
J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
[TBL] [Abstract][Full Text] [Related]
34. Saposins: structure, function, distribution, and molecular genetics.
Kishimoto Y; Hiraiwa M; O'Brien JS
J Lipid Res; 1992 Sep; 33(9):1255-67. PubMed ID: 1402395
[TBL] [Abstract][Full Text] [Related]
35. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
[TBL] [Abstract][Full Text] [Related]
36. Expression and specificity of human GM2 activator protein.
Wu YY; Lockyer JM; Sugiyama E; Pavlova NV; Li YT; Li SC
J Biol Chem; 1994 Jun; 269(23):16276-83. PubMed ID: 8206933
[TBL] [Abstract][Full Text] [Related]
37. Identity of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide.
Vogel A; Fürst W; Abo-Hashish MA; Lee-Vaupel M; Conzelmann E; Sandhoff K
Arch Biochem Biophys; 1987 Dec; 259(2):627-38. PubMed ID: 3426245
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of acid ceramidase activity by saposin D.
Azuma N; O'Brien JS; Moser HW; Kishimoto Y
Arch Biochem Biophys; 1994 Jun; 311(2):354-7. PubMed ID: 8203897
[TBL] [Abstract][Full Text] [Related]
39. Methionine oxidation within the cerebroside-sulfate activator protein (CSAct or Saposin B).
Whitelegge JP; Penn B; To T; Johnson J; Waring A; Sherman M; Stevens RL; Fluharty CB; Faull KF; Fluharty AL
Protein Sci; 2000 Sep; 9(9):1618-30. PubMed ID: 11045609
[TBL] [Abstract][Full Text] [Related]
40. Expression, purification, crystallization, and preliminary X-ray analysis of recombinant human saposin B.
Ahn VE; Faull KF; Whitelegge JP; Higginson J; Fluharty AL; Privé GG
Protein Expr Purif; 2003 Jan; 27(1):186-93. PubMed ID: 12510003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]